Published in N Engl J Med on November 07, 1991
Mapping of serotype-specific, immunodominant epitopes in the NS-4 region of hepatitis C virus (HCV): use of type-specific peptides to serologically differentiate infections with HCV types 1, 2, and 3. J Clin Microbiol (1993) 2.36
Activation of STAT3 by the hepatitis C virus core protein leads to cellular transformation. J Exp Med (2002) 2.23
Follow up of blood donors positive for antibodies to hepatitis C virus. BMJ (1994) 2.17
Spontaneous clearance of primary acute hepatitis C virus infection correlated with high initial viral RNA level and rapid HVR1 evolution. Hepatology (2012) 2.14
Hepatitis C virus core protein interacts with the cytoplasmic tail of lymphotoxin-beta receptor. J Virol (1997) 1.84
Safety of the blood supply in Latin America. Clin Microbiol Rev (2005) 1.78
Risk for transfusion-transmitted infectious diseases in Central and South America. Emerg Infect Dis (1998) 1.70
The history of the "natural history" of hepatitis C (1968-2009). Liver Int (2009) 1.63
Hepatitis C: a review for primary care physicians. CMAJ (2006) 1.60
Analysis of hepatitis C virus-inoculated chimpanzees reveals unexpected clinical profiles. J Virol (1998) 1.48
Hepatitis C: progress and problems. Clin Microbiol Rev (1994) 1.37
Effect of concurrent acute infection with hepatitis C virus on acute hepatitis B virus infection. BMJ (1993) 1.34
Clinical performance evaluation of four automated chemiluminescence immunoassays for hepatitis C virus antibody detection. J Clin Microbiol (2008) 1.32
Pharmacokinetics, safety, and antiviral effects of hypericin, a derivative of St. John's wort plant, in patients with chronic hepatitis C virus infection. Antimicrob Agents Chemother (2001) 1.14
Risk factors for hepatitis C virus infection among injecting drug users in Sydney. Genitourin Med (1994) 1.13
Risk factors for hepatitis C virus infection. A case-control study of blood donors in the Trent Region (UK). Epidemiol Infect (1994) 1.13
Prospective comparison of whole-blood- and plasma-based hepatitis C virus RNA detection systems: improved detection using whole blood as the source of viral RNA. J Clin Microbiol (1999) 1.09
Incidence, prevalence, and clinical course of hepatitis C following liver transplantation. Gastroenterology (1992) 1.04
Hepatocellular carcinoma in thalassemia: A critical review. World J Hepatol (2010) 1.04
Hepatitis C virus nonstructural 5B protein regulates tumor necrosis factor alpha signaling through effects on cellular IkappaB kinase. Mol Cell Biol (2006) 1.00
Identification and screening of 416 patients with chronic hepatitis at high risk to develop hepatocellular cancer. Ann Surg (1995) 0.99
Rapid multiplexed immunoassay for simultaneous serodiagnosis of HIV-1 and coinfections. J Clin Microbiol (2011) 0.96
Markers of hepatitis C and B virus infections among blood donors in Ho Chi Minh City and Hanoi, Vietnam. Clin Diagn Lab Immunol (1994) 0.94
Detection of antibodies to hepatitis C virus (HCV) structural proteins in anti-HCV-positive sera by an enzyme-linked immunosorbent assay using synthetic peptides as antigens. J Clin Microbiol (1993) 0.93
Hepatitis C virus infections in dialysis centers in The Netherlands: a national survey by serological and molecular methods. J Clin Microbiol (1998) 0.92
Hepatitis C markers in hemodialysis patients. J Clin Microbiol (1993) 0.92
Automated RIBA hepatitis C virus (HCV) strip immunoblot assay for reproducible HCV diagnosis. J Clin Microbiol (1998) 0.91
Hepatitis G virus: is it a hepatitis virus? West J Med (1997) 0.88
Novel evolved immunoglobulin (Ig)-binding molecules enhance the detection of IgM against hepatitis C virus. PLoS One (2011) 0.88
Mode of hepatitis C virus infection, epidemiology, and chronicity rate in the general population and risk groups. Dig Dis Sci (1996) 0.87
Viral markers in the treatment of hepatitis B and C. Gut (1993) 0.86
Update on hepatitis B and C virus diagnosis. World J Virol (2015) 0.85
Genotype dependence of hepatitis C virus antibodies detectable by the first-generation enzyme-linked immunosorbent assay with C100-3 protein. J Clin Invest (1993) 0.85
Changes in liver enzymes after surgery in anti-hepatitis C virus-positive patients. World J Surg (2004) 0.85
Determination of risk factors for hepatitis B and C in male patients suffering from chronic hepatitis. BMC Res Notes (2009) 0.85
Direct detection of circulating hepatitis C virus RNA using probes from the 5' untranslated region. J Clin Invest (1992) 0.83
Risk factors for acquisition of hepatitis C virus infection: a case series and potential implications for disease surveillance. BMC Infect Dis (2001) 0.82
TT viral infection through blood transfusion: retrospective investigation on patients in a prospective study of post-transfusion hepatitis. World J Gastroenterol (2000) 0.82
Use of a novel hepatitis C virus (HCV) major-epitope chimeric polypeptide for diagnosis of HCV infection. J Clin Microbiol (1999) 0.81
Long-term serologic follow-up of hepatitis C virus-seropositive homosexual men. Clin Diagn Lab Immunol (1995) 0.80
Chimeric hepatitis B virus core particles with parts or copies of the hepatitis C virus core protein. J Virol (1993) 0.80
Past and present hepatitis G virus infections in areas where hepatitis C is highly endemic and those where it is not endemic. J Clin Microbiol (1998) 0.79
Carbon dioxide laser ablation with immediate autografting in a full-thickness porcine burn model. Ann Surg (1998) 0.79
Patterns of progression: unpredictability and risk of decompensated cirrhosis. Dig Dis Sci (1996) 0.78
Community acquired viral hepatitis B and C in the United States. Gut (1993) 0.78
Natural interferon alpha treatment and interferon alpha receptor 2 levels in acute hepatitis C. Dig Dis Sci (2004) 0.78
Antigenic heterogeneity of the hepatitis C virus NS5A protein. J Clin Microbiol (2002) 0.78
The relationship between virological characteristics of hepatitis C virus (HCV) and reactivity to the regional specific proteins of HCV. Korean J Intern Med (2000) 0.77
Era of direct acting antivirals in chronic hepatitis C: Who will benefit? World J Hepatol (2015) 0.76
A B C d e f g ... Can J Infect Dis (1996) 0.75
Prevalence of antibodies to hepatitis C virus after blood transfusion in heart surgery. Postgrad Med J (1994) 0.75
Diabetes Mellitus is Associated With Higher Risk of Developing Decompensated Cirrhosis in Chronic Hepatitis C Patients. J Clin Gastroenterol (2017) 0.75
Prevalence of Hepatitis C virus antibody in patients with sexually transmitted diseases attending a Harrisburg, PA, STD clinic. Infect Dis Obstet Gynecol (1994) 0.75
Hepatitis C: Recent advances. Can J Infect Dis (1993) 0.75
Cost-effectiveness of screening blood donors for hepatitis C and non-A, non-B, non-C hepatitis. The EATHIS Eco Research Group. European Acute Transfusion Hepatitis Interferon Study. Eur J Clin Microbiol Infect Dis (1997) 0.75
An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science (1989) 18.79
Neurogenesis in the adult human hippocampus. Nat Med (1998) 17.53
Hepatitis B vaccine: demonstration of efficacy in a controlled clinical trial in a high-risk population in the United States. N Engl J Med (1980) 9.34
Outcomes among 562 recipients of placental-blood transplants from unrelated donors. N Engl J Med (1998) 7.07
Histological Localization of Newly-formed Desoxyribonucleic Acid. Science (1948) 6.56
Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients. N Engl J Med (1996) 6.49
A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection. N Engl J Med (1992) 5.96
Vertical transmission of hepatitis B antigen in Taiwan. N Engl J Med (1975) 5.49
Processing and cryopreservation of placental/umbilical cord blood for unrelated bone marrow reconstitution. Proc Natl Acad Sci U S A (1995) 5.15
Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors. N Engl J Med (2001) 5.14
Mucopurulent cervicitis--the ignored counterpart in women of urethritis in men. N Engl J Med (1984) 4.74
Highly active antiretroviral therapy decreases mortality and morbidity in patients with advanced HIV disease. Ann Intern Med (2001) 4.26
Sustained expression of genes delivered directly into liver and muscle by lentiviral vectors. Nat Genet (1997) 4.26
Risk factors for perinatal transmission of human immunodeficiency virus type 1 in women treated with zidovudine. Pediatric AIDS Clinical Trials Group Study 185 Team. N Engl J Med (1999) 4.12
Autoantibodies and the hepatitis-associated antigen in acute infective hepatitis. Br Med J (1970) 4.08
Survival and differentiation of adult neuronal progenitor cells transplanted to the adult brain. Proc Natl Acad Sci U S A (1995) 3.89
Underdiagnosis of genital herpes by current clinical and viral-isolation procedures. N Engl J Med (1992) 3.56
Occupational risk for hepatitis C virus infection among New York City dentists. Lancet (1992) 3.31
Hydrogen peroxide-producing lactobacilli and acquisition of vaginal infections. J Infect Dis (1996) 3.23
Genetic drift of hepatitis C virus during an 8.2-year infection in a chimpanzee: variability and stability. Virology (1992) 3.22
Multipotent progenitor cells in the adult dentate gyrus. J Neurobiol (1998) 3.15
The e antigen and vertical transmission of hepatitis B surface antigen. Am J Epidemiol (1977) 3.07
Long-term mortality after transfusion-associated non-A, non-B hepatitis. The National Heart, Lung, and Blood Institute Study Group. N Engl J Med (1992) 3.01
Antibody to hepatitis B surface antigen after a single inoculation of uncoupled synthetic HBsAg peptides. Nature (1982) 3.01
Clinical manifestations of vaginal trichomoniasis. JAMA (1989) 2.97
Antigen receptor engagement delivers a stop signal to migrating T lymphocytes. Proc Natl Acad Sci U S A (1997) 2.89
Phosphorylation of connexin43 on serine368 by protein kinase C regulates gap junctional communication. J Cell Biol (2000) 2.78
A controlled clinical trial of the efficacy of the hepatitis B vaccine (Heptavax B): a final report. Hepatology (1982) 2.74
Mechanism of cellular 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction. J Neurochem (1997) 2.62
Dilution assay statistics. J Clin Microbiol (1994) 2.61
Perinatal hepatitis B virus transmission in the United States. Prevention by passive-active immunization. JAMA (1985) 2.48
Properties and regulation of gap junctional hemichannels in the plasma membranes of cultured cells. J Cell Biol (1996) 2.47
Persistence of the serum hepatitis (SH-Australia) antigen for many years. Nature (1969) 2.37
Assay of Australia antigen and antibody employing double-antibody and solid-phase radioimmunoassay techniques and comparison with the passive hemagglutination methods. J Immunol (1971) 2.35
Differentiation of adult hippocampus-derived progenitors into olfactory neurons in vivo. Nature (1996) 2.33
Detection of hepatitis A viral antigen by radioimmunoassay. J Immunol (1975) 2.33
Risk factors for hepatitis C virus infection in United States blood donors. NHLBI Retrovirus Epidemiology Donor Study (REDS) Hepatology (2000) 2.30
Inhibition of gap junction and adherens junction assembly by connexin and A-CAM antibodies. J Cell Biol (1992) 2.30
Serum alanine aminotransferase of donors in relation to the risk of non-A,non-B hepatitis in recipients: the transfusion-transmitted viruses study. N Engl J Med (1981) 2.29
Accuracy of transesophageal echocardiography for identifying left atrial thrombi. A prospective, intraoperative study. Ann Intern Med (1995) 2.27
Efficacy of hepatitis B immune globulin for prevention of perinatal transmission of the hepatitis B virus carrier state: final report of a randomized double-blind, placebo-controlled trial. Hepatology (1983) 2.22
Hepatitis A virus infection: new insights from seroepidemiologic studies. J Infect Dis (1978) 2.21
HIV-1 messenger RNA in peripheral blood mononuclear cells as an early marker of risk for progression to AIDS. Ann Intern Med (1995) 2.18
Pooled plasma derivatives and Creutzfeldt-Jakob disease. Lancet (1995) 2.17
Multicenter evaluation of quantification methods for plasma human immunodeficiency virus type 1 RNA. J Infect Dis (1994) 2.15
Dual human immunodeficiency virus type 1 infection and recombination in a dually exposed transfusion recipient. The Transfusion Safety Study Group. J Virol (1995) 2.15
Long-term mortality and morbidity of transfusion-associated non-A, non-B, and type C hepatitis: A National Heart, Lung, and Blood Institute collaborative study. Hepatology (2001) 2.13
Association between vaginal douching and acute pelvic inflammatory disease. JAMA (1990) 2.11
Molecular cloning and characterization of the human A3 adenosine receptor. Proc Natl Acad Sci U S A (1993) 2.08
Yeast-recombinant hepatitis B vaccine. Efficacy with hepatitis B immune globulin in prevention of perinatal hepatitis B virus transmission. JAMA (1987) 2.08
HBeAg and anti-HBe detection by radioimmunoassay: correlation with vertical transmission of hepatitis B virus in Taiwan. J Med Virol (1979) 2.06
Graft-versus-host disease after double-unit cord blood transplantation has unique features and an association with engrafting unit-to-recipient HLA match. Biol Blood Marrow Transplant (2013) 2.04
Cellular immune response during uncomplicated genital infection with Chlamydia trachomatis in humans. Infect Immun (1981) 2.03
Infectious liver diseases in three groups of Copenhagen workers: correlation of hepatitis A infection to sewage exposure. Arch Environ Health (1981) 2.03
Decreased risk of symptomatic chlamydial pelvic inflammatory disease associated with oral contraceptive use. JAMA (1990) 2.02
Retracted The Fas/Fas ligand pathway and Bcl-2 regulate T cell responses to model self and foreign antigens. Immunity (1998) 2.02
Hepatitis B virus contains pre-S gene-encoded domains. Nature (1985) 2.02
Hepatitis B virus antibody in blood donors and the occurrence of non-A, non-B hepatitis in transfusion recipients. An analysis of the Transfusion-Transmitted Viruses Study. Ann Intern Med (1984) 2.01
The frequency of unrecognized type 2 herpes simplex virus infection among women. Implications for the control of genital herpes. Sex Transm Dis (1990) 2.00
Internal pH of isolated chromaffin vesicles. J Biol Chem (1976) 2.00
Proliferation, differentiation, and long-term culture of primary hippocampal neurons. Proc Natl Acad Sci U S A (1993) 2.00
Junctions between cancer cells in culture: ultrastructure and permeability. Science (1971) 1.98
Mutliple hepatitis viruses in multiple attacks of acute viral hepatitis. N Engl J Med (1977) 1.95
Hepatitis B vaccine in patients receiving hemodialysis. Immunogenicity and efficacy. N Engl J Med (1984) 1.93
Estimates of infectious disease risk factors in US blood donors. Retrovirus Epidemiology Donor Study. JAMA (1997) 1.91
Factors influencing neonatal infection by hepatitis B virus. Gastroenterology (1973) 1.91
A structurally flexible and antigenically variable N-terminal domain of the hepatitis C virus E2/NS1 protein: implication for an escape from antibody. Virology (1993) 1.90
Human T-cell lymphotropic virus type III infection in a cohort of homosexual men in New York City. JAMA (1986) 1.90
The prevalence of antibody to hepatitis A antigen in various parts of the world: a pilot study. Am J Epidemiol (1977) 1.86
The misunderstood Spanish-speaking patient. Am J Psychiatry (1980) 1.85
Establishment of a quality assurance program for human immunodeficiency virus type 1 DNA polymerase chain reaction assays by the AIDS Clinical Trials Group. ACTG PCR Working Group, and the ACTG PCR Virology Laboratories. J Clin Microbiol (1993) 1.85
Nonparenteral transmission of viral hepatitis type B (Australia antigen-associated serum hepatitis). N Engl J Med (1971) 1.84
Distribution of antibody to hepatitis a antigen in urban adult populations. N Engl J Med (1976) 1.81
Treatment process and outcomes for managed care patients receiving new antidepressant prescriptions from psychiatrists and primary care physicians. Arch Gen Psychiatry (2001) 1.79
Echocardiographic predictors of left ventricular outflow tract obstruction and systolic anterior motion of the mitral valve after mitral valve reconstruction for myxomatous valve disease. J Am Coll Cardiol (1999) 1.75
Avian reticuloendotheliosis virus (strain T): V. DNA polymerase. Virology (1972) 1.75
Viral hepatitis in a group of Boston hospitals. 3. Importance of exposure to shellfish in a nonepidemic period. N Engl J Med (1967) 1.75
Incidence of hepatitis B virus infections in preschool children in Taiwan. J Infect Dis (1982) 1.74
Etiology of cervical inflammation. Am J Obstet Gynecol (1986) 1.72
Viral hepatitis in Israel: the effect of canvassing physicians on notifications and the apparent epidemiological pattern. Bull World Health Organ (1972) 1.72
Stored placental blood for unrelated bone marrow reconstitution. Blood (1993) 1.72
Biophysical and biochemical heterogeneity of purified hepatitis B antigen. J Virol (1972) 1.70
Subdeterminants d and y of hepatitis B antigen as epidemiologic markers. Am J Epidemiol (1972) 1.70
Rapid and reversible reduction of junctional permeability in cells infected with a temperature-sensitive mutant of avian sarcoma virus. J Cell Biol (1981) 1.67